Tag Archives: Pharma

Uncertain Outlook for Pharma and Biotech Deals Following 'Turbulent' 2011

Peter Young, President and Managing Director of international investment bank Young & Partners, looks at what lies ahead for pharma and biotech following a turbulent 2011. The business outlook for pharma companies for the rest of 2012 and beyond is mixed, as pharma companies struggle to realign themselves to a new business model that will […]
Posted in Global, Guest Blog, leadership, Strategy | Also tagged , , , , | Leave a comment

The Real Way to Lean Success: Suck Out the IT Fat

The bigger the company, the thicker the sclerosis, the more they need to suck out the fat, writes Bill Drummy. Consider this: In 2011, IMS projects US Rx market growth to be 2.7 percent. The top 10 pharma companies account for 50 percent of the entire market’s revenue, but will deliver only 10 percent of […]
Posted in Guest Blog, Strategy, Technology | Also tagged , | Leave a comment

Croatia: A New Hope for European Pharma?

With Croatia’s potential accession to the EU gathering pace, Beth Kennedy looks at the implications for pharma. The growth in overall healthcare expenditure in Croatia is slow and the percentage of GDP is expected to remain the same, but the country’s accession to the EU means that European pharma would have access to cheap products […]
Posted in Emerging Markets, Europe, Global, Guest Blog, healthcare, Market Access | Also tagged , | Leave a comment

Favorite Pharma Ad of 2010

Pharm Exec has begun its search for the Ad Stars, our annual feature honoring the best in Rx advertising, and we want your input. If a great advertisement for a prescription drug — TV, print, online, radio, or any other format — has sparked your attention for its purpose, creativity, and cleverness, we’d like to […]
Posted in Advertising, Agency Insight | Also tagged , , | Leave a comment

The Potential Pain in Deficit Reduction

The US National Commission on Fiscal Responsibility’s draft report report signals US embrace of a fixed annual global budget for health care spending — experience in other countries suggests this will add to pressure for further cost controls on medicines beyond what is ordered up in Obamacare. Last week, Erskine Bowles and Alan Simpson, co-chairs […]
Posted in healthcare, Regulatory | Also tagged , , , , | 2 Comments
  • Categories

  • Meta